BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 969 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,970,000 | -4.6% | 24,474 | 0.0% | 0.62% | -13.5% |
| Q1 2021 | $2,064,000 | -44.5% | 24,474 | -47.2% | 0.71% | +4.4% |
| Q4 2020 | $3,722,000 | -2.3% | 46,386 | -2.1% | 0.68% | -9.2% |
| Q3 2020 | $3,811,000 | +14.6% | 47,386 | +22.7% | 0.75% | -14.7% |
| Q2 2020 | $3,325,000 | +6.1% | 38,621 | +0.0% | 0.88% | -16.1% |
| Q1 2020 | $3,135,000 | -22.7% | 38,619 | -20.4% | 1.05% | +13.0% |
| Q4 2019 | $4,058,000 | -5.6% | 48,532 | -1.3% | 0.93% | -12.6% |
| Q3 2019 | $4,300,000 | -23.0% | 49,157 | -28.0% | 1.06% | +1.1% |
| Q2 2019 | $5,588,000 | -1.5% | 68,232 | -2.2% | 1.05% | -4.2% |
| Q1 2019 | $5,672,000 | +23.5% | 69,757 | +0.0% | 1.10% | +6.1% |
| Q4 2018 | $4,591,000 | +5.0% | 69,752 | +23.0% | 1.03% | +2.5% |
| Q3 2018 | $4,373,000 | -16.4% | 56,727 | -19.9% | 1.01% | -3.1% |
| Q2 2018 | $5,232,000 | +12.9% | 70,852 | -0.6% | 1.04% | +8.8% |
| Q1 2018 | $4,636,000 | -2.3% | 71,277 | -2.9% | 0.96% | -0.5% |
| Q4 2017 | $4,744,000 | -11.0% | 73,389 | -13.6% | 0.96% | -5.9% |
| Q3 2017 | $5,328,000 | -47.9% | 84,902 | -49.8% | 1.02% | -52.5% |
| Q2 2017 | $10,229,000 | -11.9% | 168,966 | -24.5% | 2.15% | -4.9% |
| Q1 2017 | $11,613,000 | -7.9% | 223,928 | -21.2% | 2.26% | +24.8% |
| Q4 2016 | $12,606,000 | -20.0% | 284,300 | -14.1% | 1.81% | -8.3% |
| Q3 2016 | $15,759,000 | +8.2% | 331,075 | +2.8% | 1.98% | +0.6% |
| Q2 2016 | $14,560,000 | +5.7% | 322,000 | -4.0% | 1.96% | +8.7% |
| Q1 2016 | $13,776,000 | – | 335,350 | – | 1.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |